Применять ли стенты с лекарственным покрытием или без него при лечении острогоинфаркта миокарда с помощью чрескожногокоронарного вмешательства? (Современное состояние вопроса)

1. Диагностика и лечение острого инфаркта миокарда с подъемом сегмента ST ЭКГ. Национальные клинические рекомендации. М.: 2009; 415–500.
2. Руда М.Я. Инфаркт миокарда (острый коронарный синдром с подъемом сегмента ST). В кн.: Руководство по атеросклерозу и ишемической болезни сердца. Под ред. Е.И.Чазова, В.В.Кухарчука, С.А.Бойцова. М.: Медиа Медика, 2008.
3. Самко А.Н. Рентгеноэндоваскулярные методы лечения больных ИБС. В кн.: Руководство по атеросклерозу и ишемической болезни сердца. Под ред. Е.И.Чазова, В.В.Кухарчука, С.А.Бойцова. М.: Медиа Медика, 2008.
4. Prasad S, Meredith I. Drug-eluting stents for treatment of acute myocardial infarction: a contemporary review. Cardiol Int 2008; 9: 91–4.
5. Lagerqvist B, James S, Stenestrand U et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007; 356: 1009–19.
6. Ong A, McFadden E, de Jaegere P et al. Late angiographic stent trombosis events with drug-eluting stents. J Am Coll Cardiol 2005; 45: 2088–92.
7. Stone G, Grines C, Cox D et al. Comparison of angiography with stenting in acute myocardial infarction. N Engl J Med 2002; 346: 957–66.
8. Grines C, Cox D, Stone G et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999; 341: 1949–56.
9. Valgimigli M, Campo G, Percoco G et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute vyocardial infarction. JAMA 2008; 299: E1–E12.
10. Spaulding C, Henry P, Teiger E et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006; 355: 1093–104.
11. Laarman G, Suttorp M, Dirksen M et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006, 335: 1105–13.
12. Menichelli M, Parma A, Pucci E et al. Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction. J Am Coll Cardiol 2007; 19: 1924–30.
13. Spertus J, Peterson E, Rumsfeld J et al. The prospective registry evaluating myocardial infarction, events and recovery (PREMIER). Am Heart J 2006; 151: 589–97.
14. Valgimigli M, Campo G, Arcozzi C et al. Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein 11b\111a inhibitor infusion in patients with myocardial infarction. J Am Coll Cardiol 2007; 50: 138–45.
15. Dirksen M, Suttorp M, Vink M et al. No improvement of outcome and no increase in stent thrombosis 2 years after PCI with paclitaxel-eluting stents compared to uncoated stents for ST-segment vyocardial infarction: the PASSION trial. Eur Heart J 2007; 28 (Suppl 1): 10 (abstr.)
16. Menichelli M, Parma A, Giulivi A, Violini R. Randomized trial of sirolimus-eluting stent in acute myocardial infarction. SESAMI 2 years results. Am J Cardiol 2007; 100: 211 (abstr.).
17. Pasceri V, Patti G, Speciale G et al. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J 2007; 153 (5): 749–54.
18. Kastrati A, Dibra A, Spaulding C et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 2007; 28: 2706–13.
19. Brar S, Leon M, Mehran R et al. Meta-analysis of drug-eluting stents in acute myocardial infarction: results in 23,711 patients from randomized controlled trials and registries. Am J Cardiol 2008; 102(8): 34i (abstr.).
20. Kirtane A, Gupta A, Iyengar S et al. Drug-eluting stent versus bare-metal stent use: meta-analysis of randomized trials and observational studies. Am J Cardiol 2008; 102 (8): 31i (abstr).
21. Shishehbor M, Amini R, Oliveria L et al. Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv 2008; 1: 227–32.
22. Brodie B, Stuckey T, Downey W et al. Outcomes with drug-eluting stents versus bare-metal stents in acute ST-elevation myocardial infarction: results from STENT group. Cath Cardiovasc Interv 2008; 893–900.
23. Garro N, Capodanno D, Cammalleri V, Tamburino C. Very Late thrombosis in acute myocardial infarction: drug-eluting versus uncoated stents. EuroInterv 2008; 4: 324–30.
24. Valgimigli M, Percoco G, Malagutti P et al. Tirofiban and sirilimus-eluning stents versus abciximab and bare-metal stents for acute myocardial infarction: a randomized trial. JAMA 2005; 293: 2109–17.
25. Буза В., Карпов Ю., Самко А. и др. Оценка течения ишемической болезни сердца после установки стентов с лекарственным покрытием и голометаллических стентов: данные трехлетнего наблюдения. Кардиология 2008; 12: 34–41.
26. ACC/AHA/SCAI Guideline update for percutaneous coronary intervention. J Am Coll Cardiol 2006; 47: 1–121.
27. Самко А.Н. Стенты с лекарственным покрытием при лечении ОИМ с помощью чрескожного коронарного вмешательства. В кн.: Сердечно-сосудистая патология. Сборник трудов к 80-летию академика Е.И.Чазова. М.: Медиа Медика, 2009: 259–66.
28. Spaulding C, Manzo-Silberman S, Abizaid A et al. The use of Sirolimus-eluting CYPHER Sel ect plus coronary stent in patients with acute myocardial infarction (AMI): 1-year results fr om e-SELECT registry. EuroInterv. Suppl. 2010; 6 (14): 131.

А.Н.Самко